ClinicalTrials.Veeva

Menu

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

LG Chem logo

LG Chem

Status and phase

Completed
Phase 1

Conditions

Healthy Male Volunteers

Treatments

Drug: Ezetimibe/Rosuvastatin
Drug: Valsartan

Study type

Interventional

Funder types

Industry

Identifiers

NCT03532854
LG-EVCL001

Details and patient eligibility

About

The purpose of this study is to evaluate the drug-drug interaction between LGEV1801 and LGEV1802 in healthy male volunteers.

Enrollment

42 patients

Sex

Male

Ages

19 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy male
  • Age between 19 and 50
  • Subjects with BMI of 18~27 kg/m2 with a weight of 55kg or more
  • Subjects with SBP of 90~150 mmHg and DBP of 60~150 mmHg
  • Signed informed consent

Exclusion criteria

  • Presence of medical history or a concurrent disease
  • Has a history of hypersensitivity to IP ingredients

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

42 participants in 6 patient groups

Sequence A
Experimental group
Description:
Ezetimibe/Rosuvastatin -\> Valsartan -\> Valsartan and Ezetimibe/Rosuvastatin
Treatment:
Drug: Valsartan
Drug: Ezetimibe/Rosuvastatin
Sequence B
Experimental group
Description:
Valsartan -\> Valsartan and Ezetimibe/Rosuvastatin-\> Ezetimibe/Rosuvastatin
Treatment:
Drug: Valsartan
Drug: Ezetimibe/Rosuvastatin
Sequence C
Experimental group
Description:
Valsartan and Ezetimibe/Rosuvastatin -\> Ezetimibe/Rosuvastatin -\> Valsartan
Treatment:
Drug: Valsartan
Drug: Ezetimibe/Rosuvastatin
Sequence D
Experimental group
Description:
Ezetimibe/Rosuvastatin -\> Valsartan and Ezetimibe/Rosuvastatin-\> Valsartan
Treatment:
Drug: Valsartan
Drug: Ezetimibe/Rosuvastatin
Sequence E
Experimental group
Description:
Valsartan -\> Ezetimibe/Rosuvastatin -\> Valsartan and Ezetimibe/Rosuvastatin
Treatment:
Drug: Valsartan
Drug: Ezetimibe/Rosuvastatin
Sequence F
Experimental group
Description:
Valsartan and Ezetimibe/Rosuvastatin -\> Valsartan -\> Ezetimibe/Rosuvastatin
Treatment:
Drug: Valsartan
Drug: Ezetimibe/Rosuvastatin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems